Suppliers / SmartPractice Denmark ApS

SmartPractice Denmark ApS

Denmark 28 employees Updated 9 July 2026

SmartPractice Denmark ApS is a finished-dose manufacturer based in Denmark. It appears in 206 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, AIFA (IT) and MPA (SE). Its GMP standing is certified by ZLG (DE), EMA and US FDA. Its most recent recorded inspection, by US FDA, closed on 16 August 2024 as NAI.

0
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
206
filings across 9 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 16 August 2024 NAI US FDA
  • 5 April 2019 VAI US FDA
  • 29 January 2016 VAI US FDA
  • 28 January 2014 VAI US FDA
  • 11 November 2011 VAI US FDA
  • 17 September 2009 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
North Rhine-Westphalia, Germany Not on file
Greven, Germany Not on file
Denmark, Denmark 3003216248
Hilleroed, Denmark Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 179 3
AIFA (IT) 9 None
MPA (SE) 4 None
AEMPS (ES) 3 None
BFARM (DE) 3 None
DMP (NO) 3 None
ZLG (DE) None 6
US FDA None 1

Comparing suppliers?

Choose your molecules and target markets. SmartPractice Denmark ApS comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 16 August 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates